nodes	percent_of_prediction	percent_of_DWPC	metapath
Alizapride—DRD2—telencephalic ventricle—epilepsy syndrome	0.0581	0.27	CbGeAlD
Alizapride—DRD2—ganglion—epilepsy syndrome	0.0362	0.168	CbGeAlD
Alizapride—DRD2—hindbrain—epilepsy syndrome	0.0274	0.127	CbGeAlD
Alizapride—Amisulpride—HTR7—epilepsy syndrome	0.0188	0.309	CrCbGaD
Alizapride—DRD2—brainstem—epilepsy syndrome	0.0157	0.073	CbGeAlD
Alizapride—DRD2—forebrain—epilepsy syndrome	0.0152	0.0704	CbGeAlD
Alizapride—DRD2—telencephalon—epilepsy syndrome	0.014	0.0648	CbGeAlD
Alizapride—Sulpiride—BCHE—epilepsy syndrome	0.0138	0.226	CrCbGaD
Alizapride—DRD2—midbrain—epilepsy syndrome	0.01	0.0465	CbGeAlD
Alizapride—Remoxipride—HTR2A—epilepsy syndrome	0.00985	0.162	CrCbGaD
Alizapride—Amisulpride—HTR2A—epilepsy syndrome	0.00944	0.155	CrCbGaD
Alizapride—Remoxipride—CYP2D6—epilepsy syndrome	0.00901	0.148	CrCbGaD
Alizapride—DRD2—head—epilepsy syndrome	0.00869	0.0403	CbGeAlD
Alizapride—DRD2—nervous system—epilepsy syndrome	0.00824	0.0382	CbGeAlD
Alizapride—DRD2—central nervous system—epilepsy syndrome	0.00793	0.0368	CbGeAlD
Alizapride—DRD2—cerebellum—epilepsy syndrome	0.00775	0.036	CbGeAlD
Alizapride—DRD2—brain—epilepsy syndrome	0.0063	0.0292	CbGeAlD
Alizapride—DRD2—GPCR ligand binding—CHRM3—epilepsy syndrome	0.0014	0.00193	CbGpPWpGaD
Alizapride—DRD2—GPCRs, Class A Rhodopsin-like—BDKRB2—epilepsy syndrome	0.0014	0.00193	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—ACKR4—epilepsy syndrome	0.00138	0.00191	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—SSTR5—epilepsy syndrome	0.00137	0.0019	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—SSTR4—epilepsy syndrome	0.00137	0.0019	CbGpPWpGaD
Alizapride—DRD2—Circadian rythm related genes—AVP—epilepsy syndrome	0.00137	0.0019	CbGpPWpGaD
Alizapride—DRD2—GPCRs, Class A Rhodopsin-like—CNR1—epilepsy syndrome	0.00137	0.00189	CbGpPWpGaD
Alizapride—DRD2—Circadian rythm related genes—SIRT1—epilepsy syndrome	0.00135	0.00186	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—CX3CR1—epilepsy syndrome	0.00134	0.00185	CbGpPWpGaD
Alizapride—DRD2—GPCRs, Class A Rhodopsin-like—HTR7—epilepsy syndrome	0.00134	0.00185	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CCR10—epilepsy syndrome	0.00132	0.00182	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—CHRM2—epilepsy syndrome	0.00131	0.00181	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—BDKRB1—epilepsy syndrome	0.00131	0.00181	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—CX3CL1—epilepsy syndrome	0.00131	0.00181	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—GABBR1—epilepsy syndrome	0.00128	0.00177	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	0.00127	0.00176	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	0.00127	0.00176	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—SSTR5—epilepsy syndrome	0.00125	0.00172	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—SSTR4—epilepsy syndrome	0.00125	0.00172	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	0.00124	0.00172	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—HRH3—epilepsy syndrome	0.00122	0.00169	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—OPRM1—epilepsy syndrome	0.00121	0.00167	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CCR10—epilepsy syndrome	0.0012	0.00165	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	0.0012	0.00165	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	0.0012	0.00165	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	0.00117	0.00162	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—GRM2—epilepsy syndrome	0.00115	0.00159	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	0.00114	0.00158	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—CCR3—epilepsy syndrome	0.00114	0.00157	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—NPY—epilepsy syndrome	0.00111	0.00153	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—CXCL2—epilepsy syndrome	0.00107	0.00148	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—OXT—epilepsy syndrome	0.00107	0.00148	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—CCL3—epilepsy syndrome	0.00107	0.00148	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—CRH—epilepsy syndrome	0.00107	0.00148	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—GRM2—epilepsy syndrome	0.00105	0.00145	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—SSTR3—epilepsy syndrome	0.00104	0.00144	CbGpPWpGaD
Alizapride—DRD2—G alpha (i) signalling events—CCR5—epilepsy syndrome	0.00103	0.00142	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	0.000999	0.00138	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—NPY2R—epilepsy syndrome	0.000999	0.00138	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CCR9—epilepsy syndrome	0.000999	0.00138	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—SSTR1—epilepsy syndrome	0.000999	0.00138	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CCR8—epilepsy syndrome	0.000999	0.00138	CbGpPWpGaD
Alizapride—DRD2—Circadian rythm related genes—NOS2—epilepsy syndrome	0.00099	0.00137	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—GRM4—epilepsy syndrome	0.000979	0.00135	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—GRM3—epilepsy syndrome	0.000979	0.00135	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—SST—epilepsy syndrome	0.000968	0.00134	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—CCR2—epilepsy syndrome	0.000968	0.00134	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	0.000964	0.00133	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—SSTR2—epilepsy syndrome	0.000961	0.00133	CbGpPWpGaD
Alizapride—DRD2—G alpha (i) signalling events—AGT—epilepsy syndrome	0.000957	0.00132	CbGpPWpGaD
Alizapride—DRD2—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	0.000956	0.00132	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—ADRA2A—epilepsy syndrome	0.000948	0.00131	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—SSTR3—epilepsy syndrome	0.000946	0.00131	CbGpPWpGaD
Alizapride—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	0.000936	0.00129	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PRDM4—epilepsy syndrome	0.000933	0.00129	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.000933	0.00129	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—GRM8—epilepsy syndrome	0.000928	0.00128	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—CXCL12—epilepsy syndrome	0.00091	0.00126	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—BDKRB2—epilepsy syndrome	0.00091	0.00126	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—ARHGEF9—epilepsy syndrome	0.000907	0.00125	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—SSTR1—epilepsy syndrome	0.000907	0.00125	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CCR8—epilepsy syndrome	0.000907	0.00125	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—NPY2R—epilepsy syndrome	0.000907	0.00125	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CCR9—epilepsy syndrome	0.000907	0.00125	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—CNR1—epilepsy syndrome	0.000894	0.00123	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—GRM4—epilepsy syndrome	0.000889	0.00123	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—GRM3—epilepsy syndrome	0.000889	0.00123	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—OPRD1—epilepsy syndrome	0.000886	0.00122	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—SSTR2—epilepsy syndrome	0.000873	0.00121	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—HTR7—epilepsy syndrome	0.000872	0.0012	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CHRM1—epilepsy syndrome	0.000849	0.00117	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—PDYN—epilepsy syndrome	0.000849	0.00117	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—GRM1—epilepsy syndrome	0.000849	0.00117	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CCR7—epilepsy syndrome	0.000849	0.00117	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—GRM8—epilepsy syndrome	0.000843	0.00117	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	0.000819	0.00113	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—ACKR4—epilepsy syndrome	0.000815	0.00113	CbGpPWpGaD
Alizapride—DRD2—G alpha (i) signalling events—POMC—epilepsy syndrome	0.000805	0.00111	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—OPRD1—epilepsy syndrome	0.000804	0.00111	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—GNAO1—epilepsy syndrome	0.000804	0.00111	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	0.000802	0.00111	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—GAL—epilepsy syndrome	0.000798	0.0011	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—GRM5—epilepsy syndrome	0.000789	0.00109	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CHRM3—epilepsy syndrome	0.000789	0.00109	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CHRM1—epilepsy syndrome	0.000771	0.00107	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CCR7—epilepsy syndrome	0.000771	0.00107	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—GRM1—epilepsy syndrome	0.000771	0.00107	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—PDYN—epilepsy syndrome	0.000771	0.00107	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	0.000761	0.00105	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—BDKRB1—epilepsy syndrome	0.000742	0.00103	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CHRM2—epilepsy syndrome	0.000742	0.00103	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—SSTR4—epilepsy syndrome	0.000737	0.00102	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—SSTR5—epilepsy syndrome	0.000737	0.00102	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—AVP—epilepsy syndrome	0.000734	0.00101	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—GAL—epilepsy syndrome	0.000725	0.001	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—GABBR1—epilepsy syndrome	0.000722	0.000998	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CHRM3—epilepsy syndrome	0.000717	0.000991	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—GRM5—epilepsy syndrome	0.000717	0.000991	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CCR10—epilepsy syndrome	0.000707	0.000977	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—HRH3—epilepsy syndrome	0.000692	0.000957	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.000687	0.00095	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—OPRM1—epilepsy syndrome	0.000681	0.000942	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—BDKRB1—epilepsy syndrome	0.000674	0.000931	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CHRM2—epilepsy syndrome	0.000674	0.000931	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CX3CL1—epilepsy syndrome	0.000674	0.000931	CbGpPWpGaD
Alizapride—DRD2—Circadian rythm related genes—JUN—epilepsy syndrome	0.000656	0.000907	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—GABBR1—epilepsy syndrome	0.000656	0.000906	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CCR3—epilepsy syndrome	0.000644	0.000889	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	0.00064	0.000885	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—HRH3—epilepsy syndrome	0.000629	0.000869	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—NPY—epilepsy syndrome	0.000627	0.000867	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	0.000627	0.000866	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—CCR5—epilepsy syndrome	0.000624	0.000862	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—OPRM1—epilepsy syndrome	0.000619	0.000855	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GRM2—epilepsy syndrome	0.000618	0.000854	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—HTR2A—epilepsy syndrome	0.000611	0.000844	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—OXT—epilepsy syndrome	0.000605	0.000836	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CXCL2—epilepsy syndrome	0.000605	0.000836	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CRH—epilepsy syndrome	0.000605	0.000836	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CCR3—epilepsy syndrome	0.000584	0.000808	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—AGT—epilepsy syndrome	0.000579	0.000801	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—NPY—epilepsy syndrome	0.00057	0.000787	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—SSTR3—epilepsy syndrome	0.000559	0.000772	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CCL3—epilepsy syndrome	0.000549	0.000759	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—OXT—epilepsy syndrome	0.000549	0.000759	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CRH—epilepsy syndrome	0.000549	0.000759	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000549	0.000759	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000547	0.000756	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—SST—epilepsy syndrome	0.000547	0.000756	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000547	0.000756	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000536	0.00074	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CCR8—epilepsy syndrome	0.000536	0.00074	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CCR9—epilepsy syndrome	0.000536	0.00074	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—NPY2R—epilepsy syndrome	0.000536	0.00074	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—SSTR1—epilepsy syndrome	0.000536	0.00074	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000535	0.00074	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GRM4—epilepsy syndrome	0.000525	0.000726	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GRM3—epilepsy syndrome	0.000525	0.000726	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—DUSP4—epilepsy syndrome	0.000516	0.000713	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—SSTR2—epilepsy syndrome	0.000516	0.000713	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.000514	0.000711	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.000514	0.000711	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CNR1—epilepsy syndrome	0.000505	0.000698	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000503	0.000695	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GRM8—epilepsy syndrome	0.000498	0.000688	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PGF—epilepsy syndrome	0.000498	0.000688	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CCR2—epilepsy syndrome	0.000497	0.000687	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—SST—epilepsy syndrome	0.000497	0.000687	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000493	0.000681	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—POMC—epilepsy syndrome	0.000488	0.000674	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000486	0.000672	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—CCL2—epilepsy syndrome	0.000477	0.000659	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GNAO1—epilepsy syndrome	0.000475	0.000657	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—OPRD1—epilepsy syndrome	0.000475	0.000657	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000469	0.000649	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000467	0.000646	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000467	0.000646	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CNR1—epilepsy syndrome	0.000459	0.000634	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000457	0.000631	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GRM1—epilepsy syndrome	0.000456	0.000629	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CHRM1—epilepsy syndrome	0.000456	0.000629	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PDYN—epilepsy syndrome	0.000456	0.000629	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CCR7—epilepsy syndrome	0.000456	0.000629	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—HTR7—epilepsy syndrome	0.000447	0.000618	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000434	0.0006	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000428	0.000592	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GFAP—epilepsy syndrome	0.000428	0.000592	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GAL—epilepsy syndrome	0.000428	0.000592	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—AKT3—epilepsy syndrome	0.000426	0.000589	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GRM5—epilepsy syndrome	0.000423	0.000585	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CHRM3—epilepsy syndrome	0.000423	0.000585	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CASP2—epilepsy syndrome	0.000423	0.000585	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—AVP—epilepsy syndrome	0.000415	0.000573	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000406	0.000561	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CHRM2—epilepsy syndrome	0.000398	0.00055	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000398	0.00055	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000398	0.00055	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CDC42—epilepsy syndrome	0.000389	0.000538	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GABBR1—epilepsy syndrome	0.000387	0.000535	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—AVP—epilepsy syndrome	0.000377	0.00052	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—HRH3—epilepsy syndrome	0.000371	0.000513	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—OPRM1—epilepsy syndrome	0.000366	0.000505	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CCR5—epilepsy syndrome	0.000353	0.000487	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CCR3—epilepsy syndrome	0.000345	0.000477	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—HTR2A—epilepsy syndrome	0.000345	0.000477	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000336	0.000465	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—NPY—epilepsy syndrome	0.000336	0.000465	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—AGT—epilepsy syndrome	0.000327	0.000452	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—HSPB1—epilepsy syndrome	0.000325	0.000449	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CXCL2—epilepsy syndrome	0.000325	0.000449	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CCL3—epilepsy syndrome	0.000325	0.000449	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CRH—epilepsy syndrome	0.000325	0.000449	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—OXT—epilepsy syndrome	0.000325	0.000449	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CCR5—epilepsy syndrome	0.00032	0.000442	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—HTR2A—epilepsy syndrome	0.000313	0.000433	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—PRKCB—epilepsy syndrome	0.000303	0.000418	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—TSC1—epilepsy syndrome	0.000302	0.000417	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PTK2B—epilepsy syndrome	0.000302	0.000417	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—AGT—epilepsy syndrome	0.000297	0.000411	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CCR2—epilepsy syndrome	0.000294	0.000406	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—NTRK2—epilepsy syndrome	0.000294	0.000406	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—SST—epilepsy syndrome	0.000294	0.000406	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—DUSP6—epilepsy syndrome	0.000291	0.000402	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000287	0.000397	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PLAT—epilepsy syndrome	0.000286	0.000395	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000276	0.000381	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CXCL12—epilepsy syndrome	0.000276	0.000381	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—POMC—epilepsy syndrome	0.000276	0.000381	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—PRKCB—epilepsy syndrome	0.000275	0.00038	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—IL6ST—epilepsy syndrome	0.000274	0.000378	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CNR1—epilepsy syndrome	0.000271	0.000374	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—JUNB—epilepsy syndrome	0.000271	0.000374	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PLCB1—epilepsy syndrome	0.00027	0.000373	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—HTR7—epilepsy syndrome	0.000264	0.000365	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—HBEGF—epilepsy syndrome	0.000257	0.000355	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—AKT3—epilepsy syndrome	0.000252	0.000348	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—POMC—epilepsy syndrome	0.00025	0.000346	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—ADAM10—epilepsy syndrome	0.000246	0.00034	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CCL2—epilepsy syndrome	0.000245	0.000338	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—S100B—epilepsy syndrome	0.000233	0.000321	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—SOCS3—epilepsy syndrome	0.00023	0.000318	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CDC42—epilepsy syndrome	0.00023	0.000318	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—AVP—epilepsy syndrome	0.000222	0.000307	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—HES1—epilepsy syndrome	0.00021	0.000291	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—FYN—epilepsy syndrome	0.000205	0.000283	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	0.000204	0.000282	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	0.000203	0.000281	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	0.000197	0.000272	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—NGF—epilepsy syndrome	0.000194	0.000269	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	0.000189	0.000261	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	0.000185	0.000256	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	0.000176	0.000243	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—AGT—epilepsy syndrome	0.000176	0.000243	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—APOE—epilepsy syndrome	0.000172	0.000238	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—KDR—epilepsy syndrome	0.000169	0.000233	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	0.000162	0.000224	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	0.000162	0.000223	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—POMC—epilepsy syndrome	0.000148	0.000204	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	0.000145	0.0002	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	0.000131	0.000181	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—RELA—epilepsy syndrome	0.000121	0.000168	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	0.000119	0.000164	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	0.00011	0.000153	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	0.000109	0.000151	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—JUN—epilepsy syndrome	0.000106	0.000147	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	0.000103	0.000143	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	0.0001	0.000139	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—SRC—epilepsy syndrome	9.54e-05	0.000132	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	9.29e-05	0.000128	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	5.93e-05	8.19e-05	CbGpPWpGaD
